Harbor Advisors LLC Buys New Stake in HCA Healthcare, Inc. (NYSE:HCA)

Harbor Advisors LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 500 shares of the company’s stock, valued at approximately $203,000.

Several other large investors also recently bought and sold shares of the business. Bangor Savings Bank boosted its holdings in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC lifted its position in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $33,000. 62.73% of the stock is currently owned by institutional investors.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. UBS Group increased their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Barclays decreased their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Finally, Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $327.62 on Tuesday. HCA Healthcare, Inc. has a one year low of $250.67 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock has a market cap of $82.99 billion, a P/E ratio of 14.71, a P/E/G ratio of 1.26 and a beta of 1.63. The company has a fifty day moving average price of $371.88 and a two-hundred day moving average price of $358.84.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.81%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.